Vitamin D 60,000 IU Dosing Schedule
For treating vitamin D deficiency in adults, take 60,000 IU of vitamin D3 (cholecalciferol) once weekly for 8 weeks, followed by maintenance therapy of 1,500-2,000 IU daily. 1
Treatment Protocol for Deficiency
The standard regimen for correcting vitamin D deficiency using 60,000 IU supplements follows this structure:
- Loading phase: 60,000 IU once weekly for 8 weeks (equivalent to approximately 8,500 IU/day)
- Maintenance phase: 1,500-2,000 IU daily after completing the loading phase 1
This dosing achieves target 25(OH)D blood levels above 30 ng/mL in most adults 1. The FDA-approved product label confirms this weekly dosing schedule, stating "Take one (1) capsule each week, or as directed by your physician" 2.
Special Populations Requiring Higher Doses
Obese patients, those with malabsorption syndromes, or patients on medications affecting vitamin D metabolism (anticonvulsants, glucocorticoids, antifungals, AIDS medications) need 2-3 times higher doses:
- Loading: 6,000-10,000 IU daily for treatment
- Maintenance: 3,000-6,000 IU daily 1
Recent evidence confirms that 60,000 IU weekly for 5 weeks (total 300,000 IU) effectively achieves target levels regardless of BMI, with no safety concerns 3.
Alternative Dosing Schedules
While weekly dosing is standard, alternative evidence-based regimens include:
- Monthly dosing: 60,000 IU once monthly has been shown safe and effective in children for maintaining sufficiency 4
- Every other week: 50,000 IU every 2 weeks maintains levels between 35-50 ng/mL 1
Safety Considerations
The 60,000 IU weekly regimen is safe and does not cause hypercalcemia or hypercalciuria when used as directed. 3 Key safety points:
- Upper tolerable limit for adults is 10,000 IU daily without medical supervision 1
- 60,000 IU weekly (approximately 8,500 IU/day) falls within safe parameters
- Blood levels need to exceed 150 ng/mL before hypercalcemia risk becomes significant 1
- No monitoring of calcium or vitamin D levels is required during standard treatment 1
Critical contraindications: Do not use in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to vitamin D toxicity, or hypervitaminosis D 2.
Important Clinical Caveats
Take with food - the supplement should be consumed with meals, though dietary fat is not required for absorption 1, 2.
Patients with granuloma-forming disorders (sarcoidosis, tuberculosis, chronic fungal infections) or lymphoma require careful monitoring as they produce 1,25(OH)2D in unregulated fashion and may develop hypercalcemia when 25(OH)D exceeds 30 ng/mL 1.
For primary hyperparathyroidism with vitamin D deficiency, treatment is appropriate but serum calcium must be monitored 1.
Current Guideline Perspective (2024)
The most recent 2024 Endocrine Society guidelines have shifted away from routine testing and treatment based on specific thresholds 5. However, they still support empiric supplementation in specific populations (pregnancy, age ≥75 years, high-risk prediabetes) using daily lower doses (400-2,500 IU daily) rather than high-dose weekly regimens 5.
Despite this shift, the 2011 guidelines remain the definitive source for treating established vitamin D deficiency, as the 2024 guidelines focus on prevention rather than treatment protocols 1.